ISSN 2149-2263 | E-ISSN 2149-2271 Home      
Volume : 22 Issue : 5
Current Issue Archive Popular Article Ahead of Print

Quick Search

The role of rivaroxaban in left ventricular thrombi [Anatol J Cardiol]
Anatol J Cardiol. 2019; 21(1): 47-50 | DOI: 10.14744/AnatolJCardiol.2018.48313  

The role of rivaroxaban in left ventricular thrombi

Mahmoud Abdelnaby1, Abdallah Almaghraby2, Ola Abdelkarim2, Yehia Saleh3, Basma Hammad4, Haitham Badran5
1Cardiology and Angiology Unit, Department of Clinical and Experimental Internal Medicine, Medical Research Institute, University of Alexandria; Alexandria-Egypt
2Department of Cardiology, Faculty of Medicine, University of Alexandria; Alexandria-Egypt
3Department of Internal Medicine, Michigan State University; East Lansing, Michigan-United States of America
4Department of Cardiology, Massachusetts General Hospital; Boston-United States of America
5Department of Cardiology, Ain Shams University; Cairo-Egypt

Keywords: Left ventricular apical thrombi, Novel Oral Anticoagulants (NOACs), Rivaroxaban, Vitamin K Antagonist (VKA), Acute Coronary Syndromes (ACS), Dual Antiplatelet Therapy (DAPT)

Mahmoud Abdelnaby, Abdallah Almaghraby, Ola Abdelkarim, Yehia Saleh, Basma Hammad, Haitham Badran. The role of rivaroxaban in left ventricular thrombi. Anatol J Cardiol. 2019; 21(1): 47-50

Corresponding Author: Abdallah Almaghraby, Egypt

Full Text PDF
Download citation
Reference Manager
Share with email
Send email to author

Similar articles
Google Scholar

KARE Publishing | Copyright 2018 Turkish Society of Cardiology